CCA
CBMG

Childress Capital Advisors’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Childress Capital Advisors’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-144
Closed -$3K – 1090
2020
Q4 		$3K Buy
+144
New +$2.62K ﹤0.01% 942

Childress Capital Advisors's CBMG Position: Q1 2021 in Review

Childress Capital Advisors sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 144 shares — an estimated $3K sold.

Childress Capital Advisors first reported a position in CBMG in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Childress Capital Advisors reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Childress Capital Advisors sold 144 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $3K.
  • Childress Capital Advisors first reported a position in Cellular Biomedicine Group, Inc. in Q4 2020 and held it in 1 quarter.
  • Childress Capital Advisors's Cellular Biomedicine Group, Inc. position peaked at $3K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.